Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Valentina Poletti; Fabrizia Urbinati; Sabine Charrier; Guillaume Corre; Roger Hollis; Beatriz Campo Fernandez; Samia Martin; Michael Rothe; Axel Schambach; Donald Kohn; Fulvio Mavilio

doi:10.1016/j.omtm.2018.10.014

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Valentina Poletti ¹ Fabrizia Urbinati Sabine Charrier Guillaume Corre ² Roger Hollis Beatriz Campo Fernandez Samia Martin ³ Michael Rothe Axel Schambach Donald Kohn Fulvio Mavilio ⁴

1 UNIMORE - Università degli Studi di Modena e Reggio Emilia

2 INTEGRARE - Approches génétiques intégrées et nouvelles thérapies pour les maladies rares

3 Généthon

4 Généthon

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Cellular Biology

Life Sciences [q-bio] / Biochemistry, Molecular Biology

Life Sciences [q-bio] / Quantitative Methods [q-bio.QM]

Life Sciences [q-bio] / Biotechnology

Life Sciences [q-bio] / Genetics

Life Sciences [q-bio] / Immunology

Complete list of metadatas

https://hal-univ-evry.archives-ouvertes.fr/hal-02178306
Contributor : Guillaume Corre <>
Submitted on : Tuesday, July 9, 2019 - 4:41:08 PM
Last modification on : Tuesday, August 6, 2019 - 9:02:16 AM

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Links full text

Identifiers

Collections

Citation

Export

Metrics

32

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

32